Detalles de la búsqueda
1.
Impact of HER2-Low status in metastatic gastric cancer:A real-world retrospective cohort study.
Oncology
; 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38354717
2.
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
J Cancer Educ
; 35(1): 69-75, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446981
3.
Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors.
Psychogeriatrics
; 18(5): 365-370, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29998465
4.
Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?
Sci Rep
; 14(1): 14651, 2024 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38918433
5.
The Clinical and Pathological Characteristics That Differentiate Cases With "Low Estrogen Receptor Expression" From Triple-Negative Breast Cancer.
Eur J Breast Health
; 20(1): 19-24, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38187108
6.
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.
Expert Opin Pharmacother
; 25(4): 477-484, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568074
7.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Breast
; 70: 56-62, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343321
Resultados
1 -
7
de 7
1
Próxima >
>>